Decheng Capital

Investment firm

Decheng Capital

Private equity, Venture capital

WebsiteCrunchbase profileMenlo Park·California·United States10known portfolio companies7people tracked20co-investors

Decheng Capital is a private equity firm and venture capital firm. Based in Menlo Park, California, United States. Among the 10 companies in the known portfolio are Syneron, Cellares, Aclaris Therapeutics, Phrontline Biopharma, Omniome and Excellergy.

Is Decheng Capital a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Who to pitch at Decheng Capital

Decheng Capital portfolio companies (10)

  • Syneron
  • Cellares
  • Aclaris Therapeutics
  • Phrontline Biopharma
  • Omniome
  • Excellergy
  • Ottimo Pharma
  • Polares Medical
  • YolTech Therapeutics
  • Medtech Technology

Co-investors

Funds that share portfolio companies with Decheng Capital.

Similar funds

Showing 20 of 100

About Decheng Capital

The firm's listing covers sectors AI and Healthcare, and focus areas Analytics, Biotech, Clinical Trials and Diagnostics; known deals cluster at Growth, Late-Stage and Seed.

Of the 7 people on file at Decheng Capital, Min Cui (Founder and Managing Director), Victor Tong (Managing Director) and Nick Pliam (Partner) are listed as the contacts to approach first.

Across the known portfolio, 20 co-investors appear alongside Decheng Capital, including 5Y Capital, Domain Associates and Rock Springs Capital.

Frequently asked questions

What is Decheng Capital?

Decheng Capital is a private equity firm and venture capital firm based in Menlo Park, California, United States, with a known portfolio of 10 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Decheng Capital invest in?

Listed sectors include AI and Healthcare; listed focus areas include Analytics, Biotech, Clinical Trials and Diagnostics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Decheng Capital invest at?

The known deals of Decheng Capital include Growth, Late-Stage and Seed rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Decheng Capital?

3 of the 7 people on file at Decheng Capital are listed as contacts for the firm. All 7 have their own profile page.

How do I contact Decheng Capital?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 7 people attached to the firm have their own pages, each showing whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal